Manager TitleAgeSince
Chief Executive Officer 65 2019-01-20
Director of Finance/CFO - -
Director TitleAgeSince
Chairman - -
Director/Board Member 63 2022-05-04
Director/Board Member 71 2022-05-04
Date Insider Type Main position Quantity % Market Cap.
5/11/20 Sell

Director

583,332 6.7190%
Logo Theradiag
Theradiag develops, produces, and sells in vitro diagnostic kits for detecting auto-immune diseases, allergies, and infectious diseases. The group also offers theranostic tests for monitoring biotherapies and determining patient response to treatments applied. 54.6% of net sales are abroad.
Employees
61
Sector
-
  1. Stock Market
  2. Stocks
  3. ALTER Stock